Patents Examined by Deanna K. Hall
  • Patent number: 12005264
    Abstract: Disclosed is a skin care device using plasma. The skin care device may include a first plasma generating device; and a main body configured to supply power to the first plasma generating device and to control the first plasma generating device based on an input from a user.
    Type: Grant
    Filed: August 4, 2023
    Date of Patent: June 11, 2024
    Assignee: GCS Co., Ltd.
    Inventors: Chang Sik Kim, Tae Yong Kim, Myeong Woo Kim, Hyuk Namgoong, Ha Yun Lee
  • Patent number: 12004997
    Abstract: A method is provided for treating a gland or duct of a patient. In a particular embodiment, an obstruction in a gland or duct and the orifice thereof can be alleviated; in another, a substance can be injected thereinto; in yet another, the gland can be aspirated. The method includes the step of inserting an elongated probe into a gland or duct via an orifice thereinto. In some embodiments the probe can have a longitudinal lumen therethrough, with at least one distal hole through the probe wall in fluid communication with the lumen. The lumen can be used in concert with a source of suction for removing debris from the gland or duct, and/or with a source of a fluid and pumping means, for injecting a substance into the gland or duct.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: June 11, 2024
    Assignee: MGD Innovations, Inc.
    Inventor: Steven L. Maskin
  • Patent number: 12005203
    Abstract: An articulating shaft for a steerable catheter system includes a tubular body and a plurality of wire support elements integrally formed from a single piece with the tubular body. The tubular body has a longitudinal central axis and a sealed lumen with a distal opening and a proximal opening. The wire support elements support an actuating wire. Each of the wire support elements has a feed-through opening receiving the actuating wire. A pair of adjacent wire support elements are separated from each other in an axial direction by a slot.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: June 11, 2024
    Assignee: Creganna Unlimited Company
    Inventors: Damian Muldoon, Bernard McDermott
  • Patent number: 11998234
    Abstract: A percutaneous introducer, particularly for flexible drainage tubes and with various profiles, includes a main body, the main body having a longitudinally extended tubular element arranged in the distal portion of the main body. The tubular element has a terminal arranged at the distal end of the tubular element. The percutaneous introducer has a sliding body which includes a longitudinally extended obturator arranged in the distal portion of the sliding body, the obturator being inserted and being movable longitudinally within the tubular element of the main body. The obturator includes a cutting blade arranged and fixed at the distal end of the obturator. The percutaneous introducer includes a return and positioning spring adapted to return the cutting blade to a retracted position within its seat, following the controlled exit of the cutting blade through a passage slot arranged in the terminal of the tubular element.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: June 4, 2024
    Assignee: REDAX S.P.A.
    Inventor: Lucio Gibertoni
  • Patent number: 12002560
    Abstract: A fluid injector system has a controller for operably controlling the injection of contrast and/or saline into a patient. The controller allows a user to program a diagnostic injection procedure having one or more phases according to which the contrast and/or saline will be injected into the patient so as to effect enhancement of a region thereof during an imaging procedure. It further allows the user to program a test injection procedure to be performed prior to the diagnostic injection procedure. The test injection procedure is implementable as: (a) a variable single phase test injection in which the rate at which the saline is to be delivered is selectable prior to and may be varied during performance thereof; and/or (b) a multi-phase test injection in which the rate at which the saline is to be delivered is selectable for each phase of the multi-phase test injection prior to performance thereof.
    Type: Grant
    Filed: April 8, 2019
    Date of Patent: June 4, 2024
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Corey Kemper, John Volkar, Michael Brooks, Leona Mulcahy
  • Patent number: 11992659
    Abstract: A drug delivery system is disclosed that includes a drug delivery device having a reservoir, a delivery cannula having a proximal end in fluid communication with the reservoir and a distal end to be received within a patient, and one or more controllable elements. The drug delivery system may further include one or more sensors coupled to the drug delivery device, and a controller coupled to the one or more sensors and the one or more controllable elements. The controller may be configured to use the one or more sensors to determine a condition or an operational state of the drug delivery device. Furthermore, the controller may be configured to control the controllable element based on the condition or the operational state of the drug delivery device and/or identity information stored in a memory onboard the device. A method for use with a drug delivery device is also disclosed.
    Type: Grant
    Filed: November 23, 2021
    Date of Patent: May 28, 2024
    Assignee: AMGEN INC.
    Inventors: Adam B. McCullough, Ferry Tamtoro, Huaying Yang, Mark Ka Lai Lee, Desheng Yin, Scott R. Gibson, Donald Busby, Peter V. Shultz, Keith P. Kogler, Basel Hasan Taha, Jimmie L. Ward, Christopher R. Folk, Steven William Badelt
  • Patent number: 11992663
    Abstract: An autoinjector comprises a housing, a product container, a displaceable needle protection sleeve, a plunger rod displaceable by a preloaded discharge spring, a dose setting element with at least two different rotational positions relative to the housing, and a dosing sleeve. The dosing sleeve or the plunger rod has a dose selection stop, and the other has at least one dosing stop. By rotating the dose setting element, the dosing sleeve or the plunger rod is rotated relative to the other. Upon displacement of the needle protection sleeve, the spring displaces the plunger rod, whereby, if the dose setting element is in the first rotational position, the dose selection stop and the first dosing stop strikes against each other, and, if the dose setting element is in the second rotational position, one of the dose selection stop and the first dosing stop is or can be moved past the other.
    Type: Grant
    Filed: April 7, 2022
    Date of Patent: May 28, 2024
    Assignee: Ypsomed AG
    Inventors: Markus Tschirren, Christian Schrul, Jürg Hirschel
  • Patent number: 11986638
    Abstract: The present disclosure relates to a safety mechanism for a medicament delivery device for mechanical shock absorption, which safety mechanism has a medicament delivery member sleeve, a housing having a proximal opening arranged to receive the medicament delivery member sleeve, wherein the medicament delivery member sleeve is axially displaceable inside the housing, between an extended position in which a proximal end portion of the medicament delivery member sleeve extends proximally from the housing and a retracted position in which the proximal end portion is received by the housing, wherein the proximal end portion has a resilient structure, enabling compression of the proximal end portion in the distal direction upon impact of an axial force greater than a threshold value.
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: May 21, 2024
    Assignee: SHL Medical AG
    Inventor: Stephan Olson
  • Patent number: 11986317
    Abstract: The present invention is directed to a device and method for monitoring and assessment of movement disorder symptoms. The device and method disclosed herein are particularly amenable to remote monitoring of a subject's movement disorder symptoms. Briefly stated, in certain preferred embodiments of the present invention the movement disorder monitoring device accompanies a subject to a remote location where the device is used to record data relating to the severity of a subject's movement disorder symptoms over a period of time. This data is then subsequently used by physicians or other clinicians in optimizing and assessing treatment options directed at alleviating a subject's movement disorder symptoms. The method and device of the present invention can be used to monitor symptoms of a number of movement disorders including but not limited to dystonia, essential tremor, Huntington's disease, various ataxias, multiple sclerosis, psychogenic tremor, and Parkinson's disease.
    Type: Grant
    Filed: March 22, 2022
    Date of Patent: May 21, 2024
    Assignee: Great Lakes Neuro Technologies Inc.
    Inventors: Dustin A. Heldman, Joseph P. Giuffrida, Thomas O. Mera
  • Patent number: 11980740
    Abstract: An insertion device to assist in accessing an access port that has been subcutaneously implanted in the body of a patient is disclosed. The implanted access port is accessed by a needle of a needle assembly, such as a needle-based infusion set. The insertion device may include a body having a stabilizing portion and a guide portion. The stabilizing portion stabilizes a position of the implanted access port when the body is placed on the skin of the patient atop the implanted access port. The guide portion is designed to guide a needle of the needle assembly along a predetermined path such that the needle transcutaneously pierces a septum of the implanted access port.
    Type: Grant
    Filed: September 13, 2021
    Date of Patent: May 14, 2024
    Assignee: C. R. Bard, Inc.
    Inventors: Glade H. Howell, Bradley J. VanderStek, Jeremy B. Cox, Laurie M. Whetstone, Manikantan Shanmugham, Jason R. Stats, Kenneth W. Sykes
  • Patent number: 11980722
    Abstract: Described herein are devices, methods and kits for assessing and/or enhancing the accessibility of a subvalvular space of a heart, accessing the subvalvular space of the heart (e.g., to provide access for one or more other devices), and/or positioning one or more devices in the subvalvular space of the heart. The devices described herein may, for example, comprise catheters that may be used to manipulate one or more chordae tendineae, diagnostic catheters having different sizes and/or shapes (e.g., different curvatures), guide catheters having different sizes and/or shapes (e.g., different curvatures), and visualization catheters. In some variations, the devices, methods, and/or kits may be used to visualize a target site, such as a subannular groove of a heart valve. In certain variations, the devices, methods, and/or kits may be used to manipulate chordae tendineae to provide additional space in a ventricle of a heart (e.g., enhancing the accessibility of the ventricle).
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: May 14, 2024
    Assignee: Ancora Heart, Inc.
    Inventor: Mariel Fabro
  • Patent number: 11975177
    Abstract: An injection device and method are shown. Devices and methods include a forceps and a needle advancement mechanism to clamp a portion of tissue and control a depth of penetration of the needle between gripping ends of the forceps. An injection device and method are shown where selected components of the injection device such as a syringe and forceps are disposable, while the remaining portions of the injection device are reusable. Devices and methods are shown that utilize micro-needles to control a depth of penetration.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: May 7, 2024
    Inventor: Edwin Ryan
  • Patent number: 11975173
    Abstract: A device which regulates the flow of a medical liquid includes a first and a second body, the first body featuring a first passage fluidly connected to a regulation channel, the second body featuring a second passage which may be positioned at a desired point of the regulation channel and set, during use, in fluid passage communication with the first passage by means of the regulation channel. The device includes a limiter which, once engaged, can no longer be disengaged during normal use of the regulation device, the first body or the second body featuring at least a first stop, and the limiter, when engaged, encountering the first stop in order to prevent the second passage being positioned in a predetermined portion of the regulation channel and/or at the first passage.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: May 7, 2024
    Assignee: PHOENIX R&D S.R.L.
    Inventors: Luciano Casarotto, Michele Maggiolo, Fiorenzo Casarotto, Leobaldo Casarotto
  • Patent number: 11957847
    Abstract: A deflectable catheter shaft with compression resistance coils configured to create different curve shapes when the catheter is steered or deflected in different directions. One or more compression resistance coils may include an elongated-pitch section. The compression resistance coils may be pull wire compression coils or body compression coils.
    Type: Grant
    Filed: December 30, 2020
    Date of Patent: April 16, 2024
    Assignee: St. Jude Medical, Cardiology Division, Inc.
    Inventor: Alexander Carson Houck
  • Patent number: 11957854
    Abstract: MVO is treated by introducing injectate into blood vessels affected by MVO at precise flow rates, while blocking retrograde flow, such that the natural pumping of the heart aids in forcing the injectate into the affected microvessels. Monitoring pressure distal of an occlusion balloon is used to determine treatment effectiveness and heart health.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: April 16, 2024
    Assignee: CorFlow Therapeutics AG
    Inventors: Robert S. Schwartz, Martin T. Rothman, Jon H. Hoem
  • Patent number: 11957866
    Abstract: A blinding cap for covering a needle shield that is covering a needle of a syringe includes an elongated body extending between a proximal end and an opposing distal end, the body at least partially bounding a chamber. An annular sleeve projects from the proximal end of the body and at least partially bounds a channel. A first flange radially inwardly projects from the body into the chamber, the first flange at least partially bounding an opening that provides communication between the chamber and the channel.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: April 16, 2024
    Assignee: Fisher Clinical Services GmbH
    Inventors: Patrick Locati, Guido Hunkeler, Alain Duerr
  • Patent number: 11957884
    Abstract: One or more embodiments of the disclosure relate, generally, to a system to assist with manual dosing of insulin. Such a system may include a glucose sensor system, a reusable insulin dosing detector, and a recommendation system. The reusable insulin dosing detector may be configured to be reversibly connectable to a disposable component that may form part of an insulin manual delivery assembly. The reusable insulin dosing detector may be configured to detect insulin delivery associated with the insulin manual delivery assembly. The recommendation system may be configured to analyze blood glucose data and determine adjustments to insulin therapy settings.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: April 16, 2024
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Patent number: 11957867
    Abstract: A syringe stabilizing apparatus has a base and a syringe support. The syringe support is vertically disposed above the base, elevating a fluid-filled portion of an infusion set vertically above the base and orienting a delivery end of the fluid-filled portion upwardly relative to a horizontal plane to take advantage of a gravitational effect on a fluid during delivery of the fluid from the fluid-filled portion to a patient. The syringe support comprises a first retainer and a selectively actuated tube clamp. The first retainer has an opening in which a rigid portion of the infusion set is received and retained therein without further user intervention. The selectively actuated tube clamp is operatively aligned with the first retainer. A flexible tube extending from the rigid portion of the infusion set extends through the selectively actuated tube clamp.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: April 16, 2024
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Scott Richard Ariagno, Angela Teresa Muriset, Daniel Edward Roush, Denise A. Alexander, Madeleine Clare Gibson, Gin-Fu Chen
  • Patent number: 11951295
    Abstract: An apparatus (1) for CRRT is provided comprising a blood circuit (10, 20, 30, 60) with a blood removal line (20), a treatment unit (10), and a blood return line (30). A replacement fluid container (78) is configured for containing a medical fluid, a pre-infusion line (70) has a first end (70-1) connected to the replacement fluid container (78) and a second end (70-2) connected to the blood removal line (20) and a blood pump (22) is active on the blood circuit. A replacement fluid pump (72) is active on the pre-infusion line (70), a dialysate circuit (40, 50, 70) comprises an effluent line (50) configured for discharging fluid from the second chamber, and a control unit (80) is connected to the replacement fluid pump (72) and to the blood pump (22) and is configured for performing a rinse-back procedure for restituting blood to a patient.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: April 9, 2024
    Assignee: Gambro Lundia AB
    Inventors: Thierry Court, Dominique Pouchoulin
  • Patent number: 11951280
    Abstract: Provided is a wearable, self-contained drug infusion or medical device capable of communicating with a host controller or other external devices via a personal area network (PAN). The medical device utilizes a PAN transceiver for communication with other devices in contact with a user's body, such as a physiological sensor or host controller, by propagating a current across the user's body via capacitive coupling. The wearable nature of the medical device and the low power requirements of the PAN communication system enable the medical device to utilize alternative energy harvesting techniques for powering the device. The medical device preferably utilizes thermal, kinetic and other energy harvesting techniques for capturing energy from the user and the environment during normal use of the medical device. A system power distribution unit is provided for managing the harvested energy and selectively supplying power to the medical device during system operation.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: April 9, 2024
    Assignee: Becton, Dickinson and Company
    Inventors: Richard Savoie, Gary Searle